Araim Pharmaceuticals Selects Ferry Breedveld as Acting CEO

November 21, 2019   |   November 2019 Bond Updates
TARRYTOWN, N.Y., Nov. 21, 2019 /PRNewswire/ -- Araim Pharmaceuticals, Inc. is pleased to announce the appointment of Ferdinand "Ferry" Breedveld, MD, PhD, the Chairman of the Board at Araim, as the organization's acting Chief Executive Officer. Dr. Breedveld brings more than 40 years of...

View more at: https://www.prnewswire.com:443/news-releases/araim-pharmaceuticals-selects-ferry-breedveld-as-acting-ceo-300962606.html
 
Related News
Home| About us | Contact us http://www.bondupdatesdailynews.com/